$111 Million is the total value of Endurant Capital Management LP's 43 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 120.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $15,888,177 | +320.4% | 179,568 | +311.8% | 14.27% | +332.4% |
TMO | New | THERMO FISHER SCIENTIFIC INC | $7,009,948 | – | 13,849 | +100.0% | 6.30% | – |
BRKR | Buy | BRUKER CORP | $6,932,495 | +515.1% | 111,276 | +629.9% | 6.23% | +532.7% |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $6,531,188 | +50.1% | 96,444 | +58.6% | 5.87% | +54.4% |
ANTM | Buy | ELEVANCE HEALTH INC | $5,878,605 | +134.8% | 13,501 | +139.5% | 5.28% | +141.5% |
AVTR | New | AVANTOR INC | $4,782,567 | – | 226,877 | +100.0% | 4.30% | – |
MRK | Sell | MERCK & CO INC | $4,569,333 | -19.7% | 44,384 | -10.0% | 4.10% | -17.4% |
ARGX | Buy | ARGENX SEsponsored adr | $4,477,766 | +347.9% | 9,108 | +255.1% | 4.02% | +360.6% |
CNMD | New | CONMED CORP | $4,234,086 | – | 41,984 | +100.0% | 3.80% | – |
COO | New | COOPER COS INC | $3,667,609 | – | 11,533 | +100.0% | 3.29% | – |
HUM | New | HUMANA INC | $3,203,248 | – | 6,584 | +100.0% | 2.88% | – |
TXG | New | 10X GENOMICS INC | $2,930,565 | – | 71,044 | +100.0% | 2.63% | – |
SBRA | New | SABRA HEALTH CARE REIT INC | $2,840,860 | – | 203,792 | +100.0% | 2.55% | – |
OHI | New | OMEGA HEALTHCARE INVS INC | $2,655,121 | – | 80,070 | +100.0% | 2.38% | – |
BSX | Sell | BOSTON SCIENTIFIC CORP | $2,528,750 | -23.3% | 47,893 | -21.5% | 2.27% | -21.1% |
KIDS | Buy | ORTHOPEDIATRICS CORP | $2,251,648 | +378.1% | 70,364 | +555.1% | 2.02% | +392.0% |
ABC | New | CENCORA INC | $2,088,732 | – | 11,606 | +100.0% | 1.88% | – |
SYK | New | STRYKER CORPORATION | $2,062,369 | – | 7,547 | +100.0% | 1.85% | – |
INSM | INSMED INC | $2,006,643 | +19.7% | 79,471 | 0.0% | 1.80% | +23.1% | |
ZBH | New | ZIMMER BIOMET HOLDINGS INC | $1,961,493 | – | 17,479 | +100.0% | 1.76% | – |
New | QUIDELORTHO CORP | $1,953,601 | – | 26,747 | +100.0% | 1.76% | – | |
DXCM | New | DEXCOM INC | $1,930,750 | – | 20,694 | +100.0% | 1.73% | – |
THC | Sell | TENET HEALTHCARE CORP | $1,788,979 | -62.1% | 27,151 | -53.2% | 1.61% | -61.0% |
ABT | New | ABBOTT LABS | $1,747,174 | – | 18,040 | +100.0% | 1.57% | – |
CI | Sell | THE CIGNA GROUP | $1,740,164 | -76.0% | 6,083 | -76.4% | 1.56% | -75.3% |
PODD | New | INSULET CORP | $1,415,952 | – | 8,878 | +100.0% | 1.27% | – |
ETNB | Buy | 89BIO INC | $1,268,442 | +128.6% | 82,153 | +180.6% | 1.14% | +135.3% |
HOLX | New | HOLOGIC INC | $1,231,850 | – | 17,750 | +100.0% | 1.11% | – |
OCUL | Sell | OCULAR THERAPEUTIX INC | $1,110,640 | -41.6% | 353,707 | -4.0% | 1.00% | -39.9% |
BRKS | New | AZENTA INC | $974,790 | – | 19,422 | +100.0% | 0.88% | – |
TARS | New | TARSUS PHARMACEUTICALS INC | $846,723 | – | 47,649 | +100.0% | 0.76% | – |
AHCO | New | ADAPTHEALTH CORP | $818,427 | – | 89,937 | +100.0% | 0.74% | – |
AXSM | New | AXSOME THERAPEUTICS INC | $786,542 | – | 11,254 | +100.0% | 0.71% | – |
IQV | Sell | IQVIA HLDGS INC | $776,376 | -82.0% | 3,946 | -79.4% | 0.70% | -81.5% |
BLUE | Sell | BLUEBIRD BIO INC | $765,426 | -17.3% | 251,785 | -10.5% | 0.69% | -15.0% |
OLMA | Buy | OLEMA PHARMACEUTICALS INC | $723,377 | +99.4% | 58,573 | +45.8% | 0.65% | +105.0% |
New | VENTYX BIOSCIENCES INC | $641,046 | – | 18,458 | +100.0% | 0.58% | – | |
New | ARCELLX INC | $507,989 | – | 14,158 | +100.0% | 0.46% | – | |
GDRX | New | GOODRX HLDGS INC | $491,443 | – | 87,290 | +100.0% | 0.44% | – |
SELB | Sell | SELECTA BIOSCIENCES INC | $480,513 | -37.5% | 453,314 | -33.9% | 0.43% | -35.6% |
TLT | New | ISHARES TR20 yr tr bd etf | $301,546 | – | 3,400 | +100.0% | 0.27% | – |
NVST | New | ENVISTA HOLDINGS CORPORATION | $300,742 | – | 10,787 | +100.0% | 0.27% | – |
ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $243,316 | -68.0% | 311,944 | -62.0% | 0.22% | -67.0% |
VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -20,754 | -100.0% | -0.29% | – |
BTAI | Exit | BIOXCEL THERAPEUTICS INCcall | $0 | – | -57,100 | -100.0% | -0.33% | – |
MASI | Exit | MASIMO CORP | $0 | – | -2,850 | -100.0% | -0.41% | – |
ACHC | Exit | ACADIA HEALTHCARE COMPANY IN | $0 | – | -9,153 | -100.0% | -0.64% | – |
ZTS | Exit | ZOETIS INCcl a | $0 | – | -7,643 | -100.0% | -1.15% | – |
TEVA | Exit | TEVA PHARMACEUTICAL INDS LTDcall | $0 | – | -175,000 | -100.0% | -1.15% | – |
VTR | Exit | VENTAS INC | $0 | – | -41,575 | -100.0% | -1.72% | – |
EHC | Exit | ENCOMPASS HEALTH CORP | $0 | – | -32,710 | -100.0% | -1.93% | – |
MDT | Exit | MEDTRONIC PLC | $0 | – | -27,181 | -100.0% | -2.09% | – |
QGEN | Exit | QIAGEN NV | $0 | – | -62,708 | -100.0% | -2.46% | – |
CAH | Exit | CARDINAL HEALTH INC | $0 | – | -31,696 | -100.0% | -2.62% | – |
BDX | Exit | BECTON DICKINSON & CO | $0 | – | -13,360 | -100.0% | -3.08% | – |
A | Exit | AGILENT TECHNOLOGIES INC | $0 | – | -45,762 | -100.0% | -4.80% | – |
LH | Exit | LABORATORY CORP AMER HLDGS | $0 | – | -32,569 | -100.0% | -6.86% | – |
BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -93,600 | -100.0% | -7.08% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -6,100 | -100.0% | -23.70% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
LABORATORY CORP AMER HLDGS | 31 | Q2 2023 | 8.7% |
ELEVANCE HEALTH INC | 29 | Q3 2023 | 8.8% |
BECTON DICKINSON & CO | 28 | Q2 2023 | 9.8% |
MCKESSON CORP | 27 | Q1 2023 | 4.4% |
CENCORA INC | 26 | Q3 2023 | 5.9% |
HOLOGIC INC | 24 | Q3 2023 | 7.5% |
JOHNSON & JOHNSON | 24 | Q4 2021 | 5.5% |
ZIMMER HLDGS INC | 23 | Q3 2023 | 7.5% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2023 | 5.5% |
DAVITA INC | 22 | Q1 2021 | 4.9% |
View Endurant Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
INVACARE HOLDINGS Corp | September 08, 2023 | 39,488,569 | 84.9% |
AZIYO BIOLOGICS, INC. | March 21, 2023 | 576,253 | 4.9% |
Oxford Immunotec Global PLCSold out | February 17, 2021 | 0 | 0.0% |
View Endurant Capital Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
SC 13D/A | 2023-09-08 |
13F-HR | 2023-08-14 |
3/A | 2023-05-24 |
13F-HR | 2023-05-15 |
3 | 2023-05-15 |
SC 13D | 2023-05-15 |
SC 13G/A | 2023-03-21 |
SC 13G/A | 2023-02-14 |
View Endurant Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.